Geron Corp.

NASDAQ:GERN   3:17:42 PM EDT
1.39
+0.02 (+1.84%)
Other Pre-Announcement

Geron Corporation Reports Greater Than 90% Enrollment In Imerge Phase 3 And Expected Top-Line Results Accelerated To First Quarter Of 2023

Published: 08/16/2021 21:14 GMT
Geron Corp. (GERN) - Oration Reports Greater Than 90% Enrollment in Imerge Phase 3 and Expected Top-line Results Accelerated to First Quarter of 2023.
Q2 Loss per Share $0.09.
Q2 Earnings per Share Estimate $-0.09 -- Refinitiv Ibes Data (analyst estimates).
Financial Resources, Expected Future Non-dilutive Funding Under Current Debt Facility, Expected to Fund Operations Through End of Q1 2023.